|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US5004687A
(en)
|
1985-05-21 |
1991-04-02 |
University Of Georgia Research Foundation, Inc. |
Insect virus vector with broadened host range
|
|
US4868103A
(en)
|
1986-02-19 |
1989-09-19 |
Enzo Biochem, Inc. |
Analyte detection by means of energy transfer
|
|
US5273876A
(en)
|
1987-06-26 |
1993-12-28 |
Syntro Corporation |
Recombinant human cytomegalovirus containing foreign gene
|
|
WO1990009441A1
(en)
|
1989-02-01 |
1990-08-23 |
The General Hospital Corporation |
Herpes simplex virus type i expression vector
|
|
GB8923123D0
(en)
|
1989-10-13 |
1989-11-29 |
Connaught Lab |
A vaccine for human immunodeficiency virus
|
|
EP1285967A3
(en)
|
1990-09-21 |
2005-03-02 |
Chiron Corporation |
Human retroviral packaging cell line
|
|
DE69131908T3
(de)
|
1991-02-19 |
2008-04-03 |
Oxford Biomedica (Uk) Ltd. |
Viruspartikel mit veraendertem wirtspektrum
|
|
GB9105383D0
(en)
|
1991-03-14 |
1991-05-01 |
Immunology Ltd |
An immunotherapeutic for cervical cancer
|
|
US6013638A
(en)
|
1991-10-02 |
2000-01-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
|
|
DE69326967T2
(de)
|
1992-01-17 |
2000-06-15 |
Lakowicz, Joseph R. |
Phasenmodulationsenergieübertragungsfluoroimmunassay
|
|
AU3972893A
(en)
|
1992-04-03 |
1993-11-08 |
Baylor College Of Medicine |
Gene therapy using the intestine
|
|
US6130074A
(en)
|
1992-06-01 |
2000-10-10 |
American Cyanamid Company Five Giralda Farms |
Recombinant insect virus with reduced capacity for host-to-host transmission in the environment and methods to produce said virus
|
|
SE9201984D0
(sv)
|
1992-06-29 |
1992-06-29 |
Pharmacia Biosensor Ab |
Improvement in optical assays
|
|
JP3147514B2
(ja)
|
1992-07-08 |
2001-03-19 |
住友電装株式会社 |
電線送給装置
|
|
WO1994012629A1
(en)
|
1992-12-02 |
1994-06-09 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
|
WO1994023048A2
(en)
|
1993-04-06 |
1994-10-13 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Gibbon ape leukemia virus-based retroviral vectors
|
|
US6133028A
(en)
|
1993-05-28 |
2000-10-17 |
Transgene S.A. |
Defective adenoviruses and corresponding complementation lines
|
|
US6120764A
(en)
|
1993-06-24 |
2000-09-19 |
Advec, Inc. |
Adenoviruses for control of gene expression
|
|
US6140087A
(en)
|
1993-06-24 |
2000-10-31 |
Advec, Inc. |
Adenovirus vectors for gene therapy
|
|
EP0728202A4
(en)
|
1993-11-12 |
1997-04-23 |
Univ Case Western Reserve |
EPISOMIC EXPRESSION VECTOR FOR HUMAN GENE THERAPY
|
|
US5731172A
(en)
|
1994-03-09 |
1998-03-24 |
Sumitomo Pharmaceuticals Company, Ltd. |
Recombinant adenovirus and process for producing the same
|
|
ES2267101T3
(es)
|
1994-04-29 |
2007-03-01 |
PHARMACIA & UPJOHN COMPANY LLC |
Vacuna contra virus de inmunodeficiencia felina.
|
|
US5604090A
(en)
|
1994-06-06 |
1997-02-18 |
Fred Hutchinson Cancer Research Center |
Method for increasing transduction of cells by adeno-associated virus vectors
|
|
US5662897A
(en)
|
1994-07-27 |
1997-09-02 |
U. Of Ga Research Foundation |
Insect viruses, sequences, insecticidal compositions and methods of use
|
|
US5693508A
(en)
|
1994-11-08 |
1997-12-02 |
Chang; Lung-Ji |
Retroviral expression vectors containing MoMLV/CMV-IE/HIV-TAR chimeric long terminal repeats
|
|
JP3770333B2
(ja)
|
1995-03-15 |
2006-04-26 |
大日本住友製薬株式会社 |
組換えｄｎａウイルスおよびその製造方法
|
|
GB9506782D0
(en)
|
1995-04-01 |
1995-05-24 |
British Biotech Pharm |
Retroviral vectors
|
|
CA2226575C
(en)
|
1995-07-27 |
2011-10-18 |
Genentech, Inc. |
Stabile isotonic lyophilized protein formulation
|
|
AU722196B2
(en)
|
1995-08-30 |
2000-07-27 |
Genzyme Corporation |
Chromatographic purification of adenovirus and AAV
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US6020192A
(en)
|
1996-01-18 |
2000-02-01 |
University Of Florida |
Humanized green fluorescent protein genes and methods
|
|
US5874304A
(en)
|
1996-01-18 |
1999-02-23 |
University Of Florida Research Foundation, Inc. |
Humanized green fluorescent protein genes and methods
|
|
JP2000506727A
(ja)
|
1996-03-05 |
2000-06-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
組換え生ネコ免疫不全ウイルスおよびプロウイルスｄｎａワクチン
|
|
US5952221A
(en)
|
1996-03-06 |
1999-09-14 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a first and second nucleic acid sequence
|
|
US5891646A
(en)
|
1997-06-05 |
1999-04-06 |
Duke University |
Methods of assaying receptor activity and constructs useful in such methods
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
US6143565A
(en)
|
1997-08-22 |
2000-11-07 |
The United States Of America As Represented By The Secretary Of Agriculture |
Stable insect virus-cell expression system
|
|
US6893827B1
(en)
|
2000-02-07 |
2005-05-17 |
Applera Corporation |
Receptor function assay for G-protein coupled receptors and orphan receptors by reporter enzyme mutant complementation
|
|
NZ526720A
(en)
|
2000-12-28 |
2007-11-30 |
Altus Pharmaceuticals Inc |
Crystallisation of whole antibodies or fragments thereof, on a large scale and a process allowing an alternative route for delivery of therapeutic antibodies
|
|
WO2003008446A1
(fr)
|
2001-07-19 |
2003-01-30 |
Mitsubishi Pharma Corporation |
Polypeptides se rapportant au transfert de signaux de recepteur de produits terminaux a glycation avancee
|
|
JP4734498B2
(ja)
|
2003-07-09 |
2011-07-27 |
ライフ テクノロジーズ コーポレイション |
タンパク質−タンパク質相互作用を解析する方法
|
|
US7488583B2
(en)
|
2003-09-25 |
2009-02-10 |
Odyssey Thera, Inc. |
Fragment complementation assays for G-protein-coupled receptors and their signaling pathways
|
|
JP5188804B2
(ja)
|
2004-08-03 |
2013-04-24 |
トランステック ファーマ，インコーポレイティド |
Ｒａｇｅ融合タンパク質及びその使用方法
|
|
MX2007011411A
(es)
*
|
2005-03-17 |
2007-11-13 |
Univ Columbia |
Interaccion rage/diaphanous y composiciones relacionadas y metodos.
|
|
KR100859972B1
(ko)
|
2006-02-20 |
2008-09-25 |
이화여자대학교 산학협력단 |
막투과 단백질 도메인 펩타이드
|
|
MX2008012023A
(es)
|
2006-03-21 |
2008-10-01 |
Wyeth Corp |
Metodos para prevenir y tratar enfermedades amiloidogenicas.
|
|
DK2080012T3
(da)
|
2006-11-10 |
2013-06-17 |
Dimerix Bioscience Pty Ltd |
Fremgangsmåder til analyse af testforbindelser på forbundne receptorer.
|
|
US20100249038A1
(en)
|
2007-06-12 |
2010-09-30 |
Board Of Regents, University Of Texas System |
Antagonists of the receptor for advanced glycation end-products (rage)
|
|
US8101373B2
(en)
|
2007-10-12 |
2012-01-24 |
Discoverx Corporation |
β-galactosidase donor fragments
|
|
WO2012109569A1
(en)
|
2011-02-11 |
2012-08-16 |
The Trustees Of Columbia University In The City Of New York |
The receptor for advanced glycation endproducts (rage) is a receptor for lysophosphatidic acid (lpa)
|
|
AU2012260434A1
(en)
|
2011-05-23 |
2013-10-31 |
Phylogica Limited |
Method of determining, identifying or isolating cell-penetrating peptides
|
|
JP2014527180A
(ja)
|
2011-09-14 |
2014-10-09 |
アベテルノ リミテッド |
細胞内細胞選別
|
|
JP2020531514A
(ja)
*
|
2017-08-22 |
2020-11-05 |
モナシュ・ユニヴァーシティ |
終末糖化産物受容体（ｒａｇｅ）の活性化のスクリーニングアッセイ、モジュレーター及び調節
|